Two biological companies announce merger agreement

"We are very excited about the value creation that will result from this combination for customers, employees, and investors," says Bioceres Chief Executive Officer Federico Trucco. "By combining our current commercialized products and pipelines, we will be in a position to serve all major agriculture input categories with low environmental impact, highly efficacious, biological based solutions. MBI's commercial footprint in North America and Europe will strongly complement our existing efforts in these geographies, while Bioceres' leadership in Latin America will provide an excellent channel for MBI's portfolio in these important row-crop markets. Together, we will create a winning platform in one of the most dynamic segments of agriculture."

"Our merger has the potential to accelerate global reach, broaden our product offerings, and expand our R&D programs," says Kevin Helash, Chief Executive Officer of Marrone Bio. "Consumer and grower demand is accelerating for agricultural products that help produce safe, affordable food in a sustainable manner.  We will be able to further serve that market opportunity and provide our distribution partners and our growers with greater returns on investment."

"We are excited that the scale created by this combination with Bioceres can accelerate and expand the commercialization of Marrone's existing products. The combined companies will have the quality, experience and depth of management as well as the financial resources to realize the full potential of Marrone's pipeline," says Dwight Anderson, Managing Partner at Ospraie Ag Science LLC, the largest shareholder of MBI.

Continue reading.

Photo created by aleksandarlittlewolf - www.freepik.com

Source: Greenhouse Grower